American Future Fund hits Shelley Berkley on corruption
Shelley Berkeley, who is under investigation in Congress for corruption, is about to face another obstacle in her bid for the Nevada Senate seat: an ad campaign from the American Future Fund focusing on the issue of corruption.
Berkeley was found to be one of the most corrupt members of Congress by the Citizens for Responsibility and Ethics in Washington (CREW). According to CREW, she repeatedly used her seat in Congress to advocate for the interests of her husband’s business. A huge portion of the funds her campaign has raised come from the specialist medical field relevant to this venture.
Meanwhile, she has cosponsored at least five pieces of legislation concerning kidney care since 2004. She has also opposed changes that could lower rates for dialysis treatment. In late 2007, the renal care industry opposed a proposal to change reimbursement rates for doctors and dialysis centers. The change would have bundled payments into a single reimbursement rather than individual fees. In February 2008, Rep. Berkley wrote to Rep. Pete Stark (D-CA), then chairman of the House Ways and Means Subcommittee on Health, warning him to carefully study the possible impact of the proposal before going proceeding.
Shortly before sending the letter, she received $6,000 in campaign contributions from major kidney care
companies, including DaVita, her husband’s partner in the joint venture that oversaw the Nevada
dialysis centers. DaVita has since been one of Rep. Berkley’s top campaign contributors in
both the 2010 and 2012 election cycles. The day she sent the letter, the PACs for the RPA and the Kidney Care Council, each gave her $1,000 donations.
CMS went ahead with the bundling regulations, but with changes endorsed by dialysis and drug companies.
All throughout these processes, she never disclosed her personal connection to the kidney care industry. The lack of disclosure is what really seals the deal on Berkeley’s corrupt way of doing business.